November 19, 2026 · Gynecologic oncology reports · DOI: 10.1016/j.gore.2026.102196

Beyond organ-based therapy: Genome-directed treatment of metastatic gastric-type endocervical adenocarcinoma.

Listen to this summary

This case report examines an 81-year-old woman with HPV-independent gastric-type endocervical adenocarcinoma and a concurrent pancreatic tail lesion, asking whether the two tumors share a clonal origin and whether genomic profiling can guide treatment. Next-generation sequencing revealed identical KRAS and TP53 alterations in both sites, supporting metastatic GEA with a pancreatic-like phenotype, and treatment with pancreatic cancer-directed gemcitabine and nab-paclitaxel produced a complete radiographic and metabolic response. The authors conclude that comparative molecular profiling may help individualize therapy in diagnostically challenging cases, though the single-patient response is hypothesis-generating and requires further study.

Caleigh E Smith, Christina Angeliki Tsiverioti, Robert L Debernardo

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play